Biliary tract infections (BTI), often linked to structural abnormalities like bile duct stones, pose significant treatment challenges due to drug-resistant bacteria like Pseudomonas aeruginosa. Phage ...

In a growing global trend, bacteria are evolving new ways to maneuver around medical treatments for a variety of infections.

The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in development for resistant ...

New insights into a "friendly virus" that could pave the way for cutting-edge treatments for the potentially fatal superbug C ...

Scientists are now looking to bacteriophage — viruses that infect bacteria — and their potential to treat drug-resistant ...

Known as phage therapy, it uses viruses to kill harmful bacteria in difficult-to-treat infections. Read more at ...

Returning to Boston this February, the Bacteriophage Therapy Summit is the only global platform for industry-dominated phage drug developers. Uniting 90+ Chief Executive Officers, Vice Presidents ...

Armata is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics ... is committed to advancing phage therapy with drug development ...

Now, scientists at ETH Zurich, in collaboration with Balgrist University Hospital, have created a fast and promising new test ...

“New strategies, such as antibiotic stewardship programmes, novel therapeutics (such as bacteriophage therapy), and ongoing education for healthcare workers, are essential to control bacterial ...